We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Take care when using creams to treat dry skin conditions as they can easily dry onto clothing, bedding and bandages making them more flammable.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Pharmacy, prescription-only (POM), and general sale list (GSL) medicines: apply to move your medicine to a different classification.
The epidemiology, symptoms, diagnosis and management of monkeypox virus infections.
Find out about coronavirus (COVID-19) treatments available outside of hospital, including information on free prescriptions and lateral flow tests.
How to use a before-and-after study to evaluate your digital health product.
What pet owners need to do if their animal has suspected or confirmed bovine TB.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine etrasimod (Velsipity) to treat people with moderately to severely active ulcerative colitis.
Guidance for people who have been diagnosed with a mpox infection and who have been advised to self-isolate at home.
The T32 exemption allows you to treat non-hazardous pesticide washings in a biobed or biofilter.
The National Treatment Agency for Substance Misuse (NTA) was established in 2001 to improve the availability, capacity and effectiveness of drug treatment. It became part of Public Health England in 2013.
Advice and guidance for healthcare practitioners on the health needs of migrant patients.
Find out how to prove the originating status of your goods and check if you can claim preferential tariff treatment.
Chief Medical Officer for England, Professor Chris Whitty's annual reports and lectures on medicine and public health.
Bring your pet to Great Britain - microchipping, pet passports, vaccinations
Guidance on assessing risk following rabies exposure, post-exposure treatment, and public health management of a suspected rabies case in the UK.
Help available and steps you should take if you have a medical emergency or are hospitalised abroad, including for planned treatment.
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.